NCT06799312

Brief Summary

To compare the efficacy of lesional high-frequency rTMS, contralesional cTBS, and sham stimulation in improving motor and cognitive recovery in post-stroke patients undergoing physiotherapy.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Mar 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Mar 2025Dec 2026

First Submitted

Initial submission to the registry

January 15, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 29, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 15, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 5, 2025

Status Verified

March 1, 2025

Enrollment Period

1.5 years

First QC Date

January 15, 2025

Last Update Submit

March 2, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Score in Nottingham Sensory Assessment in points

    Within the time frame of the study , around 18 months

  • Score in modified Ashworth Scale in points

    Within the time frame of the study , around 18 months

  • Score in Fugl-Meyer assessment scale in points

    Within the time frame of the study , around 18 months

Secondary Outcomes (2)

  • Cortical Excitability Improvement

    Within the time frame of the study , around 18 months

  • Enhancement of White Matter Integrity

    Within the time frame of the study , around 18 months

Study Arms (3)

Ipsilesional high frequency rTMS combined with physiotherapy

ACTIVE COMPARATOR

rTMS Protocol: Stimulation delivered to the hand area of the ipsilesional primary motor cortex (M1). Frequency: 3 Hz. Stimulation: 2 seconds per train, 37 trains per session. Total pulses: 750 per session at 130% of the resting motor threshold (RMT). Physiotherapy: Patients receive standard physiotherapy sessions.

Device: Ipsilesional high frequency rTMS combined with physiotherapy

Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy

ACTIVE COMPARATOR

rTMS Protocol: Stimulation delivered to the contralesional primary motor cortex (M1). Protocol: Continuous bursts of 3 stimuli at 50 Hz, repeated at 5 bursts per second. Duration: 40 seconds per session. Stimulation intensity: 70% of RMT with a biphasic TMS-induced current at a 45° angle to the midline. Physiotherapy: Patients receive standard physiotherapy sessions.

Device: Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy

Sham rTMS + Physiotherapy

SHAM COMPARATOR

Patients receive a sham stimulation designed to mimic rTMS without delivering active magnetic pulses. This maintains blinding for participants and investigators. Physiotherapy: Patients receive standard physiotherapy sessions.

Device: Sham rTMS + Physiotherapy

Interventions

As mentioned in details in arms description.

Ipsilesional high frequency rTMS combined with physiotherapy

As mentioned in details in arms description.

Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy

As mentioned in details in arms description.

Sham rTMS + Physiotherapy

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First-ever ischemic stroke, confirmed by imaging.
  • Stroke affecting the non-dominant hemisphere (cortical or subcortical) within the middle cerebral artery (MCA) territory.
  • Acute to subacute stage of stroke (time since onset: 48 hours to 2 weeks).
  • Ability to comply with the study protocol and interventions.

You may not qualify if:

  • Hemorrhagic stroke or bilateral stroke.
  • Severe cognitive impairment, defined as a Montreal Cognitive Assessment (MoCA) score \< 10.
  • Contraindications to TMS, such as: History of epilepsy, Metallic implants in the head, Other contraindications based on TMS safety guidelines.
  • Comorbid conditions that limit participation in rehabilitation.
  • Severe neglect or aphasia that would impede participation in therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Stroke

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Central Study Contacts

Mohammad Ahmad Korayem, Assistant lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Both participants and investigators are blinded to the intervention type, with sham rTMS serving as the control for maintaining blinding integrity.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A double blinded randomized controlled trial comparing different interventions on separate groups simultaneously.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisstant lecturer

Study Record Dates

First Submitted

January 15, 2025

First Posted

January 29, 2025

Study Start

March 15, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 5, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share